Back

Q&A: addressing AF ablation for your patients.

19 March 2018 (13:30 - 13:45)
Organised by:
Congress Presentation Part of: Uninterrupted dabigatran: exploring the impact on AF ablation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
NOACs today: safety, efficacy, reversibility.
Professor G. Lip (Liverpool, GB)
Presentation thumbnail
RE-CIRCUIT: answering the interrupted NOAC question.
Professor S. Willems (Hamburg, DE)
Presentation thumbnail
Refining AF ablation: what do RE-CIRCUIT subanalyses show us?
Doctor H. Calkins (Baltimore, US)
Presentation thumbnail
Applying breakthroughs in AF ablation to your clinical practice.
Professor D. Gupta (Liverpool, GB)

Access the full session

Session thumbnail
Uninterrupted dabigatran: exploring the impact on AF ablation

The Event

Event poster

EHRA 2018

19 March 2018 13:30 CET
You may be interested in
thumbnail
Congress Session
Complications in atrial fibrillation ablation
9 April 2024
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
17 May 2025
thumbnail
ESC TV Today
Episode 17: Coronary sinus reducer - Best strategies to reach LDL cholesterol goals
5 June 2025
thumbnail
Congress Presentation
Discussant review - PVI-SHAM-AF
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources